APO RESEARCH · REPORT
Helicobacter Pylori Diagnostics
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
Product & engineering
Understand the product.
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
Selected research
Industry Research
Helicobacter Pylori Diagnostics Industry Research Report 2026
Market perspective
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.
Report Scope
Read the full market overview
This report quantifies the global Helicobacter Pylori Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Helicobacter Pylori Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Helicobacter Pylori Diagnostics Market by Company
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept
Helicobacter Pylori Diagnostics Segment by Type
Invasive Techniques
Non-invasive Techniques
Helicobacter Pylori Diagnostics Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Helicobacter Pylori Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Helicobacter Pylori Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Invasive Techniques
- Non-invasive Techniques
Applications
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
Companies covered
- Sekisui Diagnostics
- F. Hoffmann-La Roche
- Medline Industries
- Meridian Bioscience
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Alpha Laboratories
- EKF Diagnostics
- Quidel
- Halyard Health
- Cardinal Health
- Beckman Coulter
- Agilent Technologies
- Coris BioConcept
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Helicobacter Pylori Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Invasive Techniques
- 2.2.3 Non-invasive Techniques
- 2.3 Helicobacter Pylori Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals and Clinics
- 2.3.3 Diagnostic Laboratories
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Helicobacter Pylori Diagnostics Breakdown Data by Type
- 3.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Type (2027-2032)
4 Helicobacter Pylori Diagnostics Breakdown Data by Application
- 4.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Helicobacter Pylori Diagnostics Market Perspective (2021-2032)
- 5.2 Global Helicobacter Pylori Diagnostics Growth Trends by Region
- 5.2.1 Global Helicobacter Pylori Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Helicobacter Pylori Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 Helicobacter Pylori Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 Helicobacter Pylori Diagnostics Market Dynamics
- 5.3.1 Helicobacter Pylori Diagnostics Industry Trends
- 5.3.2 Helicobacter Pylori Diagnostics Market Drivers
- 5.3.3 Helicobacter Pylori Diagnostics Market Challenges
- 5.3.4 Helicobacter Pylori Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue
- 6.1.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global Helicobacter Pylori Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Helicobacter Pylori Diagnostics Head Office and Area Served
- 6.4 Global Helicobacter Pylori Diagnostics Players, Product Type & Application
- 6.5 Global Helicobacter Pylori Diagnostics Manufacturers Established Date
- 6.6 Global Helicobacter Pylori Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Helicobacter Pylori Diagnostics Market Size (2021-2032)
- 7.2 North America Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Helicobacter Pylori Diagnostics Market Size by Country (2021-2026)
- 7.4 North America Helicobacter Pylori Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Helicobacter Pylori Diagnostics Market Size (2021-2032)
- 8.2 Europe Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Helicobacter Pylori Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe Helicobacter Pylori Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Helicobacter Pylori Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Helicobacter Pylori Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Helicobacter Pylori Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Helicobacter Pylori Diagnostics Market Size (2021-2032)
- 10.2 South America Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Helicobacter Pylori Diagnostics Market Size by Country (2021-2026)
- 10.4 South America Helicobacter Pylori Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Helicobacter Pylori Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Helicobacter Pylori Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Helicobacter Pylori Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sekisui Diagnostics
- 12.1.1 Sekisui Diagnostics Company Information
- 12.1.2 Sekisui Diagnostics Business Overview
- 12.1.3 Sekisui Diagnostics Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
- 12.1.5 Sekisui Diagnostics Recent Developments
- 12.2 F. Hoffmann-La Roche
- 12.2.1 F. Hoffmann-La Roche Company Information
- 12.2.2 F. Hoffmann-La Roche Business Overview
- 12.2.3 F. Hoffmann-La Roche Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
- 12.2.5 F. Hoffmann-La Roche Recent Developments
- 12.3 Medline Industries
- 12.3.1 Medline Industries Company Information
- 12.3.2 Medline Industries Business Overview
- 12.3.3 Medline Industries Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
- 12.3.5 Medline Industries Recent Developments
- 12.4 Meridian Bioscience
- 12.4.1 Meridian Bioscience Company Information
- 12.4.2 Meridian Bioscience Business Overview
- 12.4.3 Meridian Bioscience Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
- 12.4.5 Meridian Bioscience Recent Developments
- 12.5 Bio-Rad Laboratories
- 12.5.1 Bio-Rad Laboratories Company Information
- 12.5.2 Bio-Rad Laboratories Business Overview
- 12.5.3 Bio-Rad Laboratories Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
- 12.5.5 Bio-Rad Laboratories Recent Developments
- 12.6 Thermo Fisher Scientific
- 12.6.1 Thermo Fisher Scientific Company Information
- 12.6.2 Thermo Fisher Scientific Business Overview
- 12.6.3 Thermo Fisher Scientific Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
- 12.6.5 Thermo Fisher Scientific Recent Developments
- 12.7 Alpha Laboratories
- 12.7.1 Alpha Laboratories Company Information
- 12.7.2 Alpha Laboratories Business Overview
- 12.7.3 Alpha Laboratories Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
- 12.7.5 Alpha Laboratories Recent Developments
- 12.8 EKF Diagnostics
- 12.8.1 EKF Diagnostics Company Information
- 12.8.2 EKF Diagnostics Business Overview
- 12.8.3 EKF Diagnostics Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
- 12.8.5 EKF Diagnostics Recent Developments
- 12.9 Quidel
- 12.9.1 Quidel Company Information
- 12.9.2 Quidel Business Overview
- 12.9.3 Quidel Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
- 12.9.5 Quidel Recent Developments
- 12.10 Halyard Health
- 12.10.1 Halyard Health Company Information
- 12.10.2 Halyard Health Business Overview
- 12.10.3 Halyard Health Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
- 12.10.5 Halyard Health Recent Developments
- 12.11 Cardinal Health
- 12.11.1 Cardinal Health Company Information
- 12.11.2 Cardinal Health Business Overview
- 12.11.3 Cardinal Health Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
- 12.11.5 Cardinal Health Recent Developments
- 12.12 Beckman Coulter
- 12.12.1 Beckman Coulter Company Information
- 12.12.2 Beckman Coulter Business Overview
- 12.12.3 Beckman Coulter Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
- 12.12.5 Beckman Coulter Recent Developments
- 12.13 Agilent Technologies
- 12.13.1 Agilent Technologies Company Information
- 12.13.2 Agilent Technologies Business Overview
- 12.13.3 Agilent Technologies Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
- 12.13.5 Agilent Technologies Recent Developments
- 12.14 Coris BioConcept
- 12.14.1 Coris BioConcept Company Information
- 12.14.2 Coris BioConcept Business Overview
- 12.14.3 Coris BioConcept Revenue in Helicobacter Pylori Diagnostics Business (2021-2026)
- 12.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
- 12.14.5 Coris BioConcept Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst